InsiderTrades

Form 4 for RXST RxSight, Inc.

Accepted 2023-12-18 00:00:00 ET · period of report 2023-12-14 · accession 0001209191-23-059039 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MI 2023-12-18 2023-12-14 RXST Kurtz Ronald M MD Pres, CEO, Dir S - Sale $39.70 -40.0K 909.6K -4% -$1.59M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-12-14 S D 20,000 $39.40 889,610 I See footnote — — (F4) Represents the weighted average share price of an aggregate total of 20,000 shares sold in the price range of $39.08 to $39.87 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. (F3) Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse.
2 Common Common Stock 2023-12-14 S D 20,000 $40.01 909,610 I See footnote — — (F2) Represents the weighted average share price of an aggregate total of 20,000 shares sold in the price range of $39.5268 to $40.405 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. (F3) Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse.